Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer

Abstract

Individual and concerted actions of ER and PR highlight the prognostic and therapeutic value of PR in ER + /PR + breast cancers.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 03, 2016
Source ID
10.1126/sciadv.1501924

Entities

People

  • Allison L Zarnke
  • Anna G Dembo
  • Ganesh V Raj
  • Geoffrey L Greene
  • Gerard Tarulli
  • Hari Singhal
  • Marianne E Greene
  • Muriel LainĂ©
  • Ryan J. Bourgo
  • Shihong Ma
  • Theresa E Hickey
  • Wayne D Tilley
  • Ya-fang Chang

Organizations

  • Cancer Prevention and Research Institute of Texas
  • Ludwig Institute for Cancer Research
  • National Breast Cancer Foundation
  • National Health and Medical Research Council
  • Susan G. Komen for the Cure
  • United States Department of Defense
  • University of Adelaide
  • University of Chicago
  • University of Texas at Austin

Tags

Fields of Study

  • Psychology

Readers

  • Breast cancer cell signaling and growth regulation.